FGFR1-Induced Epithelial to Mesenchymal Transition through MAPK/PLCγ/COX-2-Mediated Mechanisms
Darren C. Tomlinson(St James's University Hospital), Margaret A. Knowles(St James's University Hospital)
Cited by 92
Related Papers
Oncogenic FGFR3 gene fusions in bladder cancer
|Human Molecular Genetics|2012|378
Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo
|British Journal of Cancer|2010|178
Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms
|Human Molecular Genetics|2008|55
RAS-inhibiting biologics identify and probe druggable pockets including an SII-α3 allosteric site
|Nature Communications|2021|43
ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer
|Scientific Reports|2019|25